Study Finds Higher Rates of Cardiovascular Complications…

PHILADELPHIA – Pregnant individuals living in states with tighter constraints on abortion access were found to be more likely to have cardiovascular complications, like hypertension, compared to peers in states with less abortion access restrictions, according to a new research letter from scientists at the Perelman School of Medicine at the University of Pennsylvania. The correlation could point to potential cardiovascular impacts for those states’ population as a whole, the researchers say. The article was recently published in the Journal of the American College of Cardiology: Advances.

The United States has the highest rate of maternal mortality among high-income countries, and cardiovascular conditions are the biggest cause of maternal mortality, making up a third of all maternal deaths in the U.S. While patients may have hypertension (high blood pressure) prior to becoming pregnant, it can occur for the first time for a patient during pregnancy.

“Severe or untreated high blood pressure is dangerous for the pregnant person and their baby; and may lead to a cascade of pregnancy complications including heart disease, liver disease, preterm birth, placental abruption, pre-eclampsia, and even eclampsia and seizures may follow,” said Alice Abernathy, MD, MSHP, an assistant professor of Obstetrics and Gynecology at Penn.

And the risks don’t end after delivering a baby.

“Those who have pre-eclampsia are more likely to have high blood pressure, kidney disease, a heart attack, and a stroke years later,” said Jennifer Lewey, MD, MPH, the director of Penn’s Women’s Cardiovascular Health Program and an assistant professor of Cardiovascular Medicine at Penn.

To conduct their study, researchers grouped states into one of three categories determined by abortion access policies – defined restrictive, intermediate, and protective. Restrictive states largely had laws that banned or severely limited abortion, whereas protective states had easier access to abortion and/or state policies protecting access to the procedure. Researchers then analyzed rates of cardiovascular conditions in pregnant patients who gave birth from 24 to 42 weeks gestation.

Within the “restrictive” states in the study, 2.4 percent of births happened in patients with chronic hypertension, compared to 1.9 in the “protective” states. Additionally, about 8 percent of births occurred from patients who had pregnancy-related hypertension in the restrictive category states, versus just under 7 percent in the “protective” states. And when it came to patients with eclampsia, a rate of 0.3 percent occurred in restrictive states, compared to 0.2 percent in protective states.”

The research team said their findings underscore the importance of keeping a watchful eye on the potential for complications among all pregnant patients.

“Obstetricians and clinicians in states with abortion restrictions should be extra vigilant in testing for and treating hypertension, as well as implementing evidence-based measures to prevent preeclampsia,” said Lewey.

Other Penn authors include Courtney A. Schreiber, Tang Li, Jinbo Chen, Howard M. Julien, Ashwin Nathan, Lauren Eberly, Sameed Ahmed M. Khatana.

Editor’s note: Lewey is supported by a grant from the NIH (K23 HL153667), Abernathy is supported by a grant from the NIH (K12-HD001265), and Khatana is supported by grants from the NIH (K23 HL153772) and American Heart Association (20CDA35320251).

Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.

The Perelman School of Medicine is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.

The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.

Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.